Moderna
MRNA
#268
Rank
$54.85 B
Marketcap
$137.91
Share price
5.95%
Change (1 day)
-14.54%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: $54.85 Billion

As of May 2022 Moderna has a market cap of $54.85 Billion. This makes Moderna the world's 268th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Moderna from 2018 to 2022

Year Market cap Change
2022$54.85 B-46.73%
2021$102.97 B149.1%
2020$41.33 B528.01%
2019$6.58 B31.11%
2018$5.02 B

End of Day market cap according to different sources

On May 15th, 2022 the market cap of Moderna was reported to be:

$54.85 Billion
by Iex Cloud
$54.85 Billion
by CompaniesMarketCap
$54.85 Billion
by Yahoo Finance
$54.85 Billion
by Nasdaq

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$465.36 B 748.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$190.43 B 247.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$228.62 B 316.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.03 B-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.97 B-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.14 B-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$15.27 B-72.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.34 B-93.90%๐Ÿ‡บ๐Ÿ‡ธ USA